A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies-Reference-Cited by-同舟云学术

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

Published:2013-09-19 Issue:9 Volume:9 Page:e1003618
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Sanders Rogier W.,Derking Ronald,Cupo Albert,Julien Jean-Philippe,Yasmeen Anila,de Val Natalia,Kim Helen J.,Blattner Claudia,de la Peña Alba Torrents,Korzun Jacob,Golabek Michael,de los Reyes Kevin,Ketas Thomas J.,van Gils Marit J.,King C. Richter,Wilson Ian A.,Ward Andrew B.,Klasse P. J.,Moore John P.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference87 articles.

1. HIV vaccine design and the neutralizing antibody problem;DR Burton;Nat Immunol,2004

2. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection;NM Flynn;J Infect Dis,2005

3. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial;PB Gilbert;J Infect Dis,2005

4. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand;P Pitisuttithum;J Infect Dis,2006

5. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure;JM Binley;J Virol,2000

Cited by 844 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of glycosylation on viral vaccines;Carbohydrate Polymers;2024-10

2. Comprehensive Insights into the Molecular Basis of HIV Glycoproteins;Applied Sciences;2024-09-13

3. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

4. Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire;PLOS Pathogens;2024-09-09

5. Strategies of rational and structure-driven vaccine design for Arenaviruses;Infection, Genetics and Evolution;2024-09